Alnylam Pharmaceuticals
ALNY
#549
Rank
S$56.81 B
Marketcap
S$430.05
Share price
-2.52%
Change (1 day)
14.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company